Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Sales | 215 | 285 | 282 | 258 | 234 |
| Gross Profit | 215 | 285 | 282 | 258 | 234 |
| Operating Expenses | 6,468 | 6,449 | 4,409 | 2,260 | 701 |
| Operating Income | -6,253 | -6,164 | -4,127 | -2,002 | -467 |
| Interest Expense | 2 | 1 | 2 | 1 | 176 |
| Other Income | 3,915 | 92 | 16 | 3 | -11,300 |
| Pre-tax Income | -2,340 | -6,073 | -4,113 | -2,000 | -11,943 |
| Net Income Continuous | -2,340 | -6,073 | -4,113 | -2,000 | -11,943 |
| Net Income | $-2,340 | $-6,073 | $-4,113 | $-2,000 | $-11,943 |
| EPS Basic Total Ops | -2.00 | -4.75 | -4.00 | -2.50 | 430.25 |
| EPS Basic Continuous Ops | -1.88 | -4.78 | -4.00 | -2.50 | 362.84 |
| EPS Diluted Total Ops | -2.00 | -4.75 | -4.00 | -2.50 | 430.25 |
| EPS Diluted Continuous Ops | -1.88 | -4.78 | -4.00 | -2.50 | 362.84 |
| EBITDA(a) | $-6,103 | $-6,013 | $-3,995 | $-1,884 | $-1,617 |